The anti-interleukin agent romilkimab showed significant benefits on skin fibrosis among patients with systemic sclerosis in a phase II trial, researchers reported. At week 24, the least squares mean ...

Substantial evidence exists that patients with scleroderma have immune dysfunction and autoimmunity, and several studies support the use of immunosuppressive treatment in these patients. Nihtyanova et ...

Patients with SSc were linked to an increased risk for hematological malignancies, specifically B-cell malignancies.

The fungal compound verticillin A, discovered more than 50 years ago, has long been regarded for its potential cancer-fighting capabilities. S cientists have now managed to artificially synthesize the ...

Jazz Pharmaceuticals plc  today announced the appointment of Thomas Riga as Chief Business Officer, effective January 1, 2026.Mr. Riga joined Jazz in April 2025 through the acquisition of Chimerix Inc ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

Nutritional issues such as ARFID are highly prevalent among patients with SSc and can lead to poor outcomes and other ...

Filling your diffuser with filtered or bottled water prevents damage from hard water. Keeping the diffuser away from electronics helps avoid mist damage. Essential oils labeled "for aromatherapy use" ...